(Q38969711)

English

Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism

scientific article

In more languages
default values for all languages
No label defined

No description defined

Statements

Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism (English)
0 references
James F Demarest
Heather Amrine-Madsen
David M Irlbeck
Kathryn M Kitrinos
CCR102881 Clinical Study Team

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit